Argentine Registry of Crohn's Disease and Ulcerative Colitis
Launched by GRUPO ARGENTINO DE ENFERMEDAD DE CROHN Y COLITIS ULCEROSA ·
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is a national study in Argentina called RADECCU, which is collecting information about people living with inflammatory bowel diseases (IBD), such as Crohn’s disease and ulcerative colitis. The goal is to understand how these conditions affect patients over time and how treatments are working in everyday medical care. Doctors from across the country are contributing information from both children and adults who have IBD.
Anyone with Crohn’s disease or ulcerative colitis who is receiving care from a participating gastroenterologist (a doctor who specializes in digestive health) may be included. If you join, there are no extra treatments or procedures; instead, your doctor will share information from your regular visits to help researchers learn more about IBD. This study is ongoing and open to all genders and ages. Being part of this registry helps improve knowledge about these diseases and could lead to better care for patients in the future.
Gender
ALL
Eligibility criteria
About Grupo Argentino De Enfermedad De Crohn Y Colitis Ulcerosa
The Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa (GACC) is a leading clinical research organization dedicated to advancing the understanding, diagnosis, and treatment of inflammatory bowel diseases in Argentina. Comprising a network of specialists and institutions, GACC focuses on fostering collaborative research, promoting evidence-based clinical practices, and improving patient outcomes through innovative therapeutic strategies and clinical trials.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Domingo C Balderramo, MD, PhD
Principal Investigator
Grupo Argentino de Enfermedad de Crohn y Colitis Ulcerosa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported